Top Markets
Coin of the day
UnitedHealth Group Incorporated UnitedHealth Group Incorporated

UnitedHealth Group Incorporated

UNH
Clasificación en acciones #46
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare... UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
Precio por acción
$374.76
Capitalización bursátil
$340.34B
Cambio (1 día)
-0.54%
Cambio (1 año)
11.31%
País
US
Comercio UnitedHealth Group Incorporated (UNH)

Categoría

Ratio P/E de UnitedHealth Group Incorporated (UNH)
Ratio P/E al September 2026 TTM: 24.66
Según los últimos informes financieros y el precio de las acciones de UnitedHealth Group Incorporated, el P/E actual (TTM) de la empresa es 24.66. Al final de 2024, la empresa tenía un P/E de 32.62.
Historial del ratio P/E de UnitedHealth Group Incorporated desde 2000 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) 24.66 16.78%
2025 21.12 -35.27%
2024 32.62 49.45%
2023 21.83 -11.30%
2022 24.61 -10.16%
2021 27.39 27.19%
2020 21.54 6.61%
2019 20.20 0.93%
2018 20.02 -0.57%
2017 20.13 -7.29%
2016 21.71 12.58%
2015 19.29 10.29%
2014 17.49 29.85%
2013 13.47 33.60%
2012 10.08 -4.41%
2011 10.55 20.84%
2010 8.73 -6.30%
2009 9.31 -14.13%
2008 10.85 -33.89%
2007 16.41 -5.51%
2006 17.36 -31.90%
2005 25.50 19.68%
2004 21.30 2.53%
2003 20.78 10.83%
2002 18.75 -22.59%
2001 24.22 -10.39%
2000 27.03 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
24.95 1.15%
US
18.86 -23.55%
US
11.96 -51.51%
US
38.26 55.12%
US
- -
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.